Evaluating the Therapeutic Efficacy of Mono- and Bivalent Affibody-Based Fusion Proteins Targeting HER3 in a Pancreatic Cancer Xenograft Model
- DOI
- 10.3390/pharmaceutics12060551
- Published
- 2020-06-13
- Container
- Pharmaceutics
- Publisher
- MDPI AG
- Open access
- unknown
Credibility signals
uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.3390/pharmaceutics12060551,
title = {Evaluating the Therapeutic Efficacy of Mono- and Bivalent Affibody-Based Fusion Proteins Targeting HER3 in a Pancreatic Cancer Xenograft Model},
author = {Charles Dahlsson Leitao and Sara S. Rinne and Mohamed Altai and Olga Vorontsova and Finn Dunås and Per Jonasson and Vladimir Tolmachev and John Löfblom and Stefan Ståhl and Anna Orlova},
year = {2020},
journal = {Pharmaceutics},
doi = {10.3390/pharmaceutics12060551},
url = {https://doi.org/10.3390/pharmaceutics12060551}
}RIS
TY - JOUR TI - Evaluating the Therapeutic Efficacy of Mono- and Bivalent Affibody-Based Fusion Proteins Targeting HER3 in a Pancreatic Cancer Xenograft Model AU - Charles Dahlsson Leitao AU - Sara S. Rinne AU - Mohamed Altai AU - Olga Vorontsova AU - Finn Dunås AU - Per Jonasson AU - Vladimir Tolmachev AU - John Löfblom AU - Stefan Ståhl AU - Anna Orlova PY - 2020 JO - Pharmaceutics DO - 10.3390/pharmaceutics12060551 UR - https://doi.org/10.3390/pharmaceutics12060551 ER -
APA
Leitao, C. D., Rinne, S. S., Altai, M., Vorontsova, O., Dunås, F., Jonasson, P., Tolmachev, V., Löfblom, J., Ståhl, S., & Orlova, A. (2020). Evaluating the Therapeutic Efficacy of Mono- and Bivalent Affibody-Based Fusion Proteins Targeting HER3 in a Pancreatic Cancer Xenograft Model. Pharmaceutics. https://doi.org/10.3390/pharmaceutics12060551
Source records
- crossref · retrieved 2026-09-26T16:23:48.026Z